Understand the source comparison
SS-LUP-332 vs Other Metabolic Modulators: Performance Research Comparison
Researchers often ask how SS-LUP-332 compares to other compounds used in muscle performance studies. The table below breaks down mechanism, typical performance gains, and key differentiators. SS-LUP-332 ERRα agonist. Mitochondrial biogenesis 50–70% increase in
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Researchers often ask how SS-LUP-332 compares to other compounds used in muscle performance studies. The table below breaks down mechanism, typical performance gains, and key differentiators.
- SS-LUP-332
- ERRα agonist. Mitochondrial biogenesis
- 50–70% increase in time-to-exhaustion
- Yes. Type IIb → Type I/IIa
- Oxidative phosphorylation, PGC-1α activation
- Best choice for isolating mitochondrial function from training effects. Produces metabolic remodeling without exercise
- GW501516 (Cardarine)
- PPARδ agonist. Fatty acid oxidation
- 60–80% increase in running distance
- Moderate. Enhances oxidative capacity
- Beta-oxidation, lipid metabolism
- Stronger endurance effect but affects lipid pathways broadly. Less specific than ERRα targeting
- AICAR
- AMPK activator. Glucose uptake
- 40–50% improvement in exercise tolerance
- Minimal. Primarily metabolic
- Glucose transport, glycolysis
- Mimics energy deficit rather than training adaptation. Doesn't increase mitochondrial density
- Resveratrol
- SIRT1 activator. Mitochondrial function
- 20–30% endurance gain (high variability)
- Weak
- NAD+ metabolism, mitochondrial biogenesis
- Inconsistent results across studies. Bioavailability issues limit reproducibility
- SS-LUP-332 stands out because it directly activates the transcriptional program underlying endurance adaptation rather than mimicking acute metabolic states. AICAR increases glucose uptake during exercise but doesn't rewire muscle fiber composition. GW501516 enhances fat oxidation but carries regulatory concerns due to tumor promotion in long-term rodent studies. SS-LUP-332's ERRα mechanism is the closest pharmacological equivalent to chronic endurance training at the cellular level.